Introduction
Magnetic Particle Imaging (MPI) is a novel medical imaging modality which enables the detection of magnetic nanoparticle tracers with high temporal and spatial resolution. To estimate the performance of potential tracers a Magnetic Particle Spectrometer (MPS) can be used. Hitherto, Resovist® is the current state of the art for MPI due to its superior performance. Since larger particle diameters are assumed to perform better in MPI signal generation particle size fractionation is expected to result in significant MPI signal enhancement.
Methods
We performed magnetic fractionation using a commercial separation column (Miltenyi Biotec) and separated at different field strength (12 mT -500 mT) starting with the original sample and in the following using the eluate of the previous step. Following, the static magnetization of the samples was measured to determine the size distribution of the separated fractions. Therefor we used the moment superposition model (MSM) assuming a bimodal distribution of particles magnetic core sizes. Additionally, the samples were analyzed using a MPS (Bruker BioSpin).
Results
We found good agreement of the bimodal model of the size distribution to the measurement data of Resovist ® (30% larger particles) as found in literature. In the fraction of 12 mT the proportion of larger particles significantly increased up to 73% and caused an increase of MPS signal by factor two. With increasing separation field strength we gradually decreased the larger fraction. The sample containing no larger particles showed a considerably smaller signal than the original sample.
Conclusion
We demonstrated the potential of improving MPI performance by fractionation of Resovist ® . As it was expected low signal amplitudes were obtained for the isolated smaller fraction, since these particles do not meet ideal parameters for MPI. However, increasing the larger fraction up to 73% by magnetic separation, improves MPI signal about a factor of two.
